Clinical Trials

NCT05702034 | ACTIVE_NOT_RECRUITING | PHASE3

12523 participants

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-02-15

Completion:

2026-10-15

Conditions

• Ischemic Stroke; Ischemic Attack, Transient

Interventions

• DRUG

No Results Yet

NCT05695430 | COMPLETED | NA

60 participants

Brief Cognitive Behavioral Therapy for People With Physical Disabilities

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-03-01

Completion:

2026-06-01

Conditions

• Suicide
• Suicide, Attempted
• Suicidal Ideation
• Disability Physical
• Disability Hearing
• Disability, Vision

Interventions

• BEHAVIORAL

No Results Yet

NCT05668858 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

70 participants

A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-02-10

Completion:

2026-12-31

Conditions

• Squamous Cell Carcinoma of Head and Neck

Interventions

• DRUG

No Results Yet

NCT05667246 | ENROLLING_BY_INVITATION | NA

52 participants

Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2024-07-25

Completion:

2026-12-31

Conditions

• Terbinafine Adverse Reaction

Interventions

• OTHER

No Results Yet

NCT05652335 | RECRUITING | PHASE1

180 participants

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-11-22

Completion:

2027-04-19

Conditions

• Relapsed or Refractory Multiple Myeloma
• Previously Treated Amyloid Light-chain (AL) Amyloidosis

Interventions

• DRUG

No Results Yet

NCT05624450 | RECRUITING | PHASE3

3527 participants

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-12-13

Completion:

2027-11-04

Conditions

• Viral Lung Infection and Acute Respiratory Failure

Interventions

• DRUG

No Results Yet

NCT05617014 | ENROLLING_BY_INVITATION

1500 participants

Alzheimer's Disease Neuroimaging Initiative 4

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2023-06-09

Completion:

2027-07-31

Conditions

• Mild Cognitive Impairment
• Alzheimer Disease
• Dementia

Interventions

• RADIATION

No Results Yet

NCT05610787 | ENROLLING_BY_INVITATION | NA

40 participants

EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-11-14

Completion:

2023-11-10

Conditions

• Heart Failure
• Transplant; Failure, Heart
• Congenital Heart Disease

Interventions

• DEVICE

No Results Yet

NCT05605353 | ACTIVE_NOT_RECRUITING

450 participants

Exploiting the Gut Microbiota and Its Metabolites in Pelvic Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2023-03-01

Completion:

2025-08-05

Conditions

• Pelvic Neoplasm

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05597033 | COMPLETED | NA

68 participants

Exercise and Vascular Function in Postmenopausal Females With Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-01-09

Completion:

2025-06-24

Conditions

• Hypertension

Interventions

• BEHAVIORAL

Results Available

NCT05596799 | COMPLETED | NA

70 participants

Facing Eating Disorder Fears for Anorexia Nervosa

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-12-08

Completion:

2026-04-27

Conditions

• Eating Disorders
• Anorexia Nervosa
• Anorexia Nervosa in Remission

Interventions

• BEHAVIORAL

No Results Yet

NCT05596331 | RECRUITING | NA

460 participants

Social Information Processing in Children: an ocUlo-pupillometric Tool for Standard Evaluation

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-01-03

Completion:

2026-01-03

Conditions

• Autism Spectrum Disorder

Interventions

• OTHER

No Results Yet

NCT05588141 | RECRUITING | PHASE1/PHASE2

96 participants

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-05-16

Completion:

2028-08-01

Conditions

• Brain Tumor
• Cancer

Interventions

• DRUG

No Results Yet

NCT05588128 | RECRUITING

350 participants

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2023-03-21

Completion:

2026-12-31

Conditions

• Prostate Cancer
• Biochemically Recurrent

Interventions

• DRUG

No Results Yet

NCT05567185 | ACTIVE_NOT_RECRUITING | PHASE1

5 participants

A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-03-03

Completion:

2025-03-11

Conditions

• Urinary Bladder Neoplasms
• Receptors, Fibroblast Growth Factor

Interventions

• DRUG

No Results Yet

NCT05565599 | ACTIVE_NOT_RECRUITING | NA

58 participants

An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-10-21

Completion:

2024-08-07

Conditions

• Non-valvular Atrial Fibrillation

Interventions

• DEVICE

No Results Yet

NCT05560932 | COMPLETED | NA

50 participants

HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-03-06

Completion:

2024-01-04

Conditions

• HIV
• Alcohol Use

Interventions

• BEHAVIORAL

Results Available

NCT05552222 | RECRUITING | PHASE3

1590 participants

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-10-25

Completion:

2031-04-30

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT05545306 | RECRUITING | NA

120 participants

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-06-06

Completion:

2027-02-02

Conditions

• Obesity
• Normal Physiology
• Healthy Volunteers

Interventions

• DIETARY_SUPPLEMENT

No Results Yet

NCT05543512 | COMPLETED | NA

68 participants

The Immune Directed Individualized Elimination Therapy (iDIET) Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-10-24

Completion:

2025-12-18

Conditions

• Eosinophilic Esophagitis
• EoE

Interventions

• DEVICE
• OTHER

Results Available

NCT05531565 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3

450 participants

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-09-13

Completion:

2026-10-20

Conditions

• Subacute Cutaneous Lupus Erythematosus
• Chronic Cutaneous Lupus Erythematosus

Interventions

• DRUG

No Results Yet

NCT05531396 | COMPLETED | NA

57 participants

Agility Training on Physical Performance, Cognitive Function and Brain Activities in Elderly

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-09-28

Completion:

2025-06-04

Conditions

• Elderly
• Healthy

Interventions

• OTHER

No Results Yet

NCT05529654 | COMPLETED | NA

100 participants

IMpella-Protected cArdiaC Surgery Trial (IMPACT)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-09-21

Completion:

2025-11-04

Conditions

• Left Ventricular Dysfunction

Interventions

• DEVICE

No Results Yet

NCT05528510 | ACTIVE_NOT_RECRUITING | PHASE3

418 participants

A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-09-13

Completion:

2024-04-02

Conditions

• Colitis, Ulcerative

Interventions

• DRUG
• OTHER

Results Available

NCT05512390 | ACTIVE_NOT_RECRUITING | PHASE1

39 participants

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-04-26

Completion:

2027-02-28

Conditions

• Diffuse Large B-Cell Lymphoma
• Chronic Lymphocytic Leukemia
• Follicular Lymphoma

Interventions

• DRUG

No Results Yet

NCT05498428 | RECRUITING | PHASE2

520 participants

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-11-11

Completion:

2027-08-17

Conditions

• Carcinoma, Non-small-Cell Lung

Interventions

• DRUG

No Results Yet

NCT05493904 | ACTIVE_NOT_RECRUITING | NA

320 participants

PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-11-01

Completion:

2024-12-05

Conditions

• Coronary Artery Disease
• Angina Pectoris

Interventions

• PROCEDURE
• DEVICE

No Results Yet

NCT05488314 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

57 participants

A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-12-13

Completion:

2027-04-28

Conditions

• Carcinoma, Non-Small-Cell Lung

Interventions

• DRUG

No Results Yet

NCT05480995 | ACTIVE_NOT_RECRUITING | PHASE2

9 participants

Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-01-17

Completion:

2026-08-31

Conditions

• Endometriosis

Interventions

• DRUG

No Results Yet

NCT05455320 | ACTIVE_NOT_RECRUITING | PHASE3

864 participants

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-10-13

Completion:

2027-07-30

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT05454787 | RECRUITING

300 participants

Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2022-06-02

Completion:

2026-10-31

Conditions

• Life Threatening Bleeding
• Factor Xa Inhibitor

No Results Yet

NCT05453903 | ACTIVE_NOT_RECRUITING | PHASE1

196 participants

A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-10-04

Completion:

2026-10-30

Conditions

• Leukemia, Myeloid, Acute

Interventions

• DRUG

No Results Yet

NCT05445908 | COMPLETED | PHASE2

184 participants

SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-08-17

Completion:

2026-07-31

Conditions

• Triple-negative Breast Cancer and HR+/HER2- BC

Interventions

• DRUG

No Results Yet

NCT05438043 | ACTIVE_NOT_RECRUITING | PHASE3

213 participants

A Study of Daratumumab

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-12-15

Completion:

2029-01-31

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT05424822 | ACTIVE_NOT_RECRUITING | PHASE1

167 participants

A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-08-18

Completion:

2025-10-31

Conditions

• Lymphoma, Non-Hodgkin
• Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

• DRUG

No Results Yet

NCT05423756 | COMPLETED | NA

118562 participants

INSPIRE Trial for Skin and Soft Tissue Infections

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2023-01-01

Completion:

2024-05-09

Conditions

• Skin and Soft Tissue (SST) Infection

Interventions

• OTHER

Results Available

NCT05421858 | RECRUITING | PHASE3

450 participants

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2024-12-11

Completion:

2028-01-30

Conditions

• Candidemia
• Candidiasis, Invasive

Interventions

• DRUG

No Results Yet

NCT05421663 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

166 participants

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-08-12

Completion:

2041-07-30

Conditions

• Lymphoma, Non-Hodgkin
• Lymphoma, B-Cell
• Lymphoma, Large B-Cell, Diffuse

Interventions

• BIOLOGICAL

No Results Yet

NCT05416255 | COMPLETED | NA

80 participants

Measuring Synovial Fluid Components

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-04-19

Completion:

2026-04-20

Conditions

• Knee Osteoarthritis

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05403476 | TERMINATED | PHASE2

4 participants

A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-08-16

Completion:

2024-10-05

Conditions

• Male Idiopathic Infertility

Interventions

• DRUG

Results Available